Clinical Trials
39 trialsEndostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
The First People's Hospital of Lianyungang
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Fudan University
FTANLCNDG
Qianfoshan Hospital
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital
Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
SLICER
Peking University
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
Peking University Cancer Hospital & Institute
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Zhejiang Cancer Hospital
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
Zhejiang Cancer Hospital
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
China International Medical Foundation
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
First Affiliated Hospital of Guangxi Medical University
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Sun Yat-sen University
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
Peking University Cancer Hospital & Institute
Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Fudan University
Trial of Endostar Combined With CHOPT for T Cell Lymphoma
Tianjin Medical University Cancer Institute and Hospital
Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)
Hunan Province Tumor Hospital
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
ChineseAMS
Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
Jiangsu Simcere Pharmaceutical Co., Ltd.
Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
Jiangsu Simcere Pharmaceutical Co., Ltd.
Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer
Zhejiang Cancer Hospital
Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma
ChineseAMS
DP-EN-RT
Sun Yat-sen University
PTCL
Fudan University
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer
Simcere Pharmaceutical Co., Ltd
OXCE
Shanghai Jiao Tong University School of Medicine